Evaluation
Recuring external evaluations by international experts form part of the backbone of quality assurance at all Ludwig Boltzmann Institutes. So far AIHTA (as LBI-HTA) has been evaluated three times.
Evaluation June 2016
- Dr. Christian Affolter (Head of Public Affairs and Health policy, CSS Insurance, Lucerne, Switzerland)
- Falk Ehmann, MD, PhD, MSc (Expert in drugs)
- Prof. Dr. Kirsten Steinhausen (absent due to illness)
- Bettina Zirpel (German Research Foundation, DFG, Bonn), Germany (reporter)
On-site visit for the continuation of LBI-HTA, October 2011
- Albert (Bert) Boer, MD, PhD, Director, Zorginstituut Nederland (ZIN) formerly Health Care Insurance Board (CVZ) , The Netherlands
- Raf Mertens, MD, Director, Belgian Health Care Knowledge Center (KCE), Belgium
- Prof. Peter Kolominsky-Rabas, MD, Director, Interdisciplinary Center for Public Health (IZPH), University of Erlangen-Nürnberg, Germany
Interim evaluation, June 2009
- Prof. John Gabbay, Emeritus professor of Public Health, University of Southampton, UK
- Prof. Andrew Stevens, Professor of Public Health, University of Birmingham, UK
- Prof. Stefan Willich, MD, MPH, Director, Institute for Social Medicine, Epidemiology and Health Economics, Charité Berlin, Germany
- Simon Sommer, Evaluation expert, Jacobs Foundation Zurich, Switzerland